title: [Concomitant therapy with cisplatin and radiotherapy in locally advanced tumors of the cervico-facial area].
abstract: Nineteen patients with locally advanced head and neck cancer were treated from November 1983 to January 1986 with standard loco-regional Radiotherapy: 2 Gy for 5 days/week up to a total dose of 70 Gy and simultaneous Cisplatinum 20 mg/m2 weekly. All patients achieved a response: 10 (52%) obtained a complete remission (CR) and 9 (48%) a partial remission (PR). Four of 9 patients in PR after chemoradiotherapy were disease-free after radical resection of the residual masses, while another patient was completely cured after second-line chemotherapy. The overall CR was then 79% (15/19). The results were analyzed according to the nodal status and showed that: 92% (11/12) of patients with initial nodal involvement (N1-2) achieved a CR and 75% of them were disease-free after a median follow-up of 23+ months, while only 57% (4/7) of patients with advanced nodal involvement (N3) obtained a CR (p greater than 0.05; NS) and 28% (2/7) of them were alive without evidence of disease (p less than 0.05) after 4+ and 30+ months. Toxicity was moderate: nausea and vomiting (grade 2-3) occurred in about 50% of patients, mucosal toxicity (grade 1-2) in 58%. Myelosuppression was negligible. No patient developed renal failure. Weekly cisplatinum administration during radiotherapy deserves further study especially in the management of patients with advanced primary tumor and minimal lymph node involvement.
authors: Divisione di Radioterapia Oncologica, Nuovo Ospedale San Gerardo, Monza.
authors: A
authors: A
authors: Colombo
authors: S
authors: S
authors: Crispino
authors: S
authors: S
authors: Barni
authors: F
authors: F
authors: Paolorossi
authors: F
authors: F
authors: Frigerio
authors: G
authors: G
authors: Tancini
authors: P
authors: P
authors: Lissoni
authors: F
authors: F
authors: Placa
authors: P
authors: P
authors: Mazzola
authors: S
authors: S
authors: Nava
mesh_terms: D000328:Adult; D000368:Aged; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011446:Prospective Studies; D011879:Radiotherapy Dosage
chemical_list: D002945:Cisplatin
vernacular_title: Terapia concomitante con cisplatino e radioterapia nei tumori del distretto cervico-facciale localmente avanzati.